Literature DB >> 19059420

Involvement of hippocampal CA3 K(ATP) channels in contextual memory.

Alexandre Betourne1, Ambre M Bertholet, Elodie Labroue, Hélène Halley, Hong Shuo Sun, Anne Lorsignol, Zhong-Ping Feng, Robert J French, Luc Penicaud, Jean-Michel Lassalle, Bernard Frances.   

Abstract

This paper evaluates the involvement of hippocampal ATP-sensitive potassium channels (K(ATP)) in learning and memory. After confirming expression of the Kir6.2 subunit in the CA3 region of C57BL/6J mice, we performed intra-hippocampal pharmacological injections of specific openers and blockers of K(ATP) channels. The opener diazoxide, the blocker tolbutamide, or a mixture of both, were bilaterally injected in the CA3 region before we subjected the animals to a fear conditioning paradigm. Diazoxide strongly impaired contextual memory of mice at both doses tested. This impairment was specifically reversed by co-injecting the blocker tolbutamide. Moreover, we studied the mnemonic abilities of mice deleted for the Kir6.2 subunit. These mice were backcrossed to C57BL/6J mice and tested in two learning paradigms. We found a significant impairment of contextual and tone memories in the Kir6.2 knock-out mice when compared with heterozygous or wild-type animals. Furthermore, these animals were also slightly impaired in a spatial version of the Morris water maze task. Our data suggest a specific involvement of hippocampal K(ATP) Kir6.2/SUR1 channels in memory processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059420     DOI: 10.1016/j.neuropharm.2008.11.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

1.  Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy.

Authors:  S Moriguchi; T Ishizuka; Y Yabuki; N Shioda; Y Sasaki; H Tagashira; H Yawo; J Z Yeh; H Sakagami; T Narahashi; K Fukunaga
Journal:  Mol Psychiatry       Date:  2016-10-25       Impact factor: 15.992

Review 2.  The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics.

Authors:  Sujay V Kharade; Colin Nichols; Jerod S Denton
Journal:  Future Med Chem       Date:  2016-05-10       Impact factor: 3.808

3.  Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063.

Authors:  Sujay V Kharade; Juan Vicente Sanchez-Andres; Mark G Fulton; Elaine L Shelton; Anna L Blobaum; Darren W Engers; Christopher S Hofmann; Prasanna K Dadi; Louise Lantier; David A Jacobson; Craig W Lindsley; Jerod S Denton
Journal:  J Pharmacol Exp Ther       Date:  2019-06-14       Impact factor: 4.030

Review 4.  Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs.

Authors:  Gifty M Jojo; Gowthamarajan Kuppusamy; Kousalya Selvaraj; Uday Krishna Baruah
Journal:  J Diabetes Metab Disord       Date:  2019-05-09

Review 5.  Molecular biology of K(ATP) channels and implications for health and disease.

Authors:  Alejandro Akrouh; S Eliza Halcomb; Colin G Nichols; Monica Sala-Rabanal
Journal:  IUBMB Life       Date:  2009-10       Impact factor: 3.885

6.  Single KATP channel opening in response to stimulation of AMPA/kainate receptors is mediated by Na+ accumulation and submembrane ATP and ADP changes.

Authors:  R Mollajew; J Toloe; S L Mironov
Journal:  J Physiol       Date:  2013-03-18       Impact factor: 5.182

7.  Diazoxide reduces status epilepticus neuron damage in diabetes.

Authors:  Chin-Wei Huang; Sheng-Nan Wu; Juei-Tang Cheng; Jing-Jane Tsai; Chao-Ching Huang
Journal:  Neurotox Res       Date:  2009-09-01       Impact factor: 3.911

8.  Isoflurane-induced spatial memory impairment in mice is prevented by the acetylcholinesterase inhibitor donepezil.

Authors:  Diansan Su; Yanxing Zhao; Beilei Wang; Huan Xu; Wen Li; Jie Chen; Xiangrui Wang
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

9.  Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.

Authors:  Christiano D C Gati; Márcia R Mortari; Elisabeth F Schwartz
Journal:  J Toxicol       Date:  2012-06-04

10.  Pregabalin attenuates excitotoxicity in diabetes.

Authors:  Chin-Wei Huang; Ming-Chi Lai; Juei-Tang Cheng; Jing-Jane Tsai; Chao-Ching Huang; Sheng-Nan Wu
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.